Independent supplement guide

Maqui Berry & Blood Sugar: What Human Research Shows

Fact checked against the cited sources. Commercial details checked September 8, 2026.

Affiliate disclosure: Glucose Guidebook may earn a commission if you purchase GlucoBerry through links on this page. That does not change the price you pay. Our editorial policy separates merchant claims from independent evidence.

Maqui berry (Aristotelia chilensis) is a dark-purple fruit rich in anthocyanins. GlucoBerry uses a standardized maqui berry extract, making the ingredient relevant to the product's core marketing story.

The human trial most relevant to GlucoBerry

A 2014 randomized, double-blind, placebo-controlled crossover study tested a standardized maqui berry extract in ten people with moderate glucose intolerance. The researchers reported a lower post-meal glucose and insulin response after the extract compared with placebo.

What this does show: a standardized maqui extract has been tested in humans under controlled conditions. What it does not show: that GlucoBerry itself has been clinically proven, that every maqui product works the same way, or that the ingredient should replace diabetes treatment.

Why ten participants is not enough for certainty

Small crossover studies can detect signals, but estimates are less stable and less generalizable than results from large, repeated randomized trials across diverse populations. The study is hypothesis-supporting rather than definitive.

How this connects to GlucoBerry

The current GlucoBerry label identifies 180 mg of standardized maqui berry extract. To understand the rest of the formula, continue to GlucoBerry ingredients or our full review.

Check Current GlucoBerry Offer

Medical note: This page is educational and does not diagnose, treat, cure or prevent disease. Do not replace prescribed diabetes treatment with a supplement. If you use insulin or other glucose-lowering medicine, ask your clinician or pharmacist about supplement interactions.

Sources